Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bitop AG
• Treatments: Beclomethasone

Criteria

Inclusion Criteria:

• Diagnosed allergic rhinitis during the observational period

Exclusion Criteria:

• Contra indications according to the label